Evaluation of luteal phase support on pregnancy rate in IUI cycles

Evaluation of luteal phase support on pregnancy rate in IUI cycles, a double blind, placebo-controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201011165181N2

Enrollment

260

Registered

2011-03-20

Start date

2011-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female infertility.

Interventions

Intervention 1: Progestron suppository, 400 mg daily, for 14 days. Intervention 2: placebo suppository, daily, 14 dayes.

Treatment - Drugs

Placebo

Progestron suppository, 400 mg daily, for 14 days

placebo suppository, daily, 14 dayes

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age10

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Biochemical pregnancy. Timepoint: 2 weeks after treatment. Method of measurement: BHCG in serum.	—

Secondary

Measure	Time frame
Clinical pregnancy. Timepoint: 8 weeks of pregnancy. Method of measurement: detect of fetal heart rate with ultrasound.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026